H3K36me3 mediated by SETD2 regulates the cell fate of mesenchymal stem cells (MSCs) in vitro and in vivo. Deficiency of SETD2 in BMSCs resulted in bone loss and bone marrow obesity. The gene discussed is SETD2; the disease is obesity due to melanocortin 4 receptor deficiency.